Invention Grant
US09567358B2 Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide
有权
使用N-（3-氟苯基）-2- {3 - [（7- {3- [乙基（2-羟乙基）氨基]丙氧基} - 喹唑啉-4-基）氨基] -1H-吡唑-5- 乙酰胺
![Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide](/docs/US/2017-02-14/US09567358B2/abs.jpg.600x600.jpg)
- Patent Title: Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide
- Patent Title (中): 使用N-（3-氟苯基）-2- {3 - [（7- {3- [乙基（2-羟乙基）氨基]丙氧基} - 喹唑啉-4-基）氨基] -1H-吡唑-5- 乙酰胺
-
Application No.: US14661657Application Date: 2015-03-18
-
Publication No.: US09567358B2Publication Date: 2017-02-14
- Inventor: Nicola Murdoch Heron , Frederic Henri Jung , Andrew Mortlock , Georges Pasquet
- Applicant: AstraZeneca AB
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agent Meaghan L. Richmond
- Priority: EP02293238 20021224; EP03291315 20030602
- Main IPC: C07D403/12
- IPC: C07D403/12 ; C07D403/14 ; C07F9/6558
![Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide](/abs-image/US/2017/02/14/US09567358B2/abs.jpg.150x150.jpg)
Abstract:
Quinazoline derivatives of formula (I): wherein A is 5-membered heteroaryl containing a nitrogen atom and one or two further nitrogen atoms; compositions containing them, processes for their preparation and their use in therapy.
Public/Granted literature
- US20150307534A1 CHEMICAL COMPOUNDS Public/Granted day:2015-10-29
Information query
